| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | growth factor receptor binding | 5.97e-05 | 173 | 25 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 6.73e-05 | 10 | 25 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 1.16e-04 | 13 | 25 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 1.16e-04 | 13 | 25 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.36e-04 | 14 | 25 | 2 | GO:0005130 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 2.82e-04 | 20 | 25 | 2 | GO:0004653 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor binding | 3.11e-04 | 21 | 25 | 2 | GO:0005149 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.75e-04 | 23 | 25 | 2 | GO:0034235 | |
| GeneOntologyMolecularFunction | cAMP binding | 4.44e-04 | 25 | 25 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.80e-04 | 26 | 25 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | filamin binding | 5.98e-04 | 29 | 25 | 2 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 5.98e-04 | 29 | 25 | 2 | GO:0035325 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 6.57e-04 | 324 | 25 | 4 | GO:0005126 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.93e-04 | 140 | 25 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.76e-04 | 33 | 25 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.14e-04 | 343 | 25 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 8.24e-04 | 34 | 25 | 2 | GO:0015125 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 8.73e-04 | 35 | 25 | 2 | GO:0008376 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.08e-03 | 39 | 25 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.48e-03 | 182 | 25 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.52e-03 | 184 | 25 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.71e-03 | 49 | 25 | 2 | GO:0051861 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.75e-03 | 193 | 25 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.85e-03 | 197 | 25 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.92e-03 | 52 | 25 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.13e-03 | 207 | 25 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.16e-03 | 208 | 25 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.38e-03 | 459 | 25 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.49e-03 | 465 | 25 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.72e-03 | 62 | 25 | 2 | GO:0003678 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.82e-03 | 1180 | 25 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.45e-03 | 70 | 25 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.75e-03 | 73 | 25 | 2 | GO:0170055 | |
| GeneOntologyMolecularFunction | channel activity | 3.85e-03 | 525 | 25 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.88e-03 | 526 | 25 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | copper ion binding | 4.26e-03 | 78 | 25 | 2 | GO:0005507 | |
| GeneOntologyMolecularFunction | transporter activity | 4.37e-03 | 1289 | 25 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | myosin binding | 5.04e-03 | 85 | 25 | 2 | GO:0017022 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.63e-03 | 90 | 25 | 2 | GO:0008028 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.66e-03 | 293 | 25 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 6.62e-03 | 310 | 25 | 3 | GO:0030246 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 6.98e-03 | 316 | 25 | 3 | GO:0035091 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 7.18e-03 | 102 | 25 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.21e-03 | 627 | 25 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | gated channel activity | 8.12e-03 | 334 | 25 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 8.79e-03 | 664 | 25 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.09e-02 | 127 | 25 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.11e-02 | 128 | 25 | 2 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.13e-02 | 129 | 25 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.38e-02 | 758 | 25 | 4 | GO:0015318 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.43e-02 | 766 | 25 | 4 | GO:0016491 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.45e-02 | 1189 | 25 | 5 | GO:0046914 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.48e-02 | 149 | 25 | 2 | GO:1990782 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.52e-02 | 151 | 25 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.54e-02 | 152 | 25 | 2 | GO:0022843 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.56e-02 | 153 | 25 | 2 | GO:0008194 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.61e-02 | 793 | 25 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | helicase activity | 1.66e-02 | 158 | 25 | 2 | GO:0004386 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.27e-04 | 14 | 25 | 2 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.47e-04 | 15 | 25 | 2 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.47e-04 | 15 | 25 | 2 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.47e-04 | 15 | 25 | 2 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.47e-04 | 15 | 25 | 2 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.67e-04 | 16 | 25 | 2 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.90e-04 | 17 | 25 | 2 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.90e-04 | 17 | 25 | 2 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.90e-04 | 17 | 25 | 2 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.13e-04 | 18 | 25 | 2 | GO:1903385 | |
| GeneOntologyBiologicalProcess | response to cAMP | 2.15e-04 | 97 | 25 | 3 | GO:0051591 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.64e-04 | 20 | 25 | 2 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.92e-04 | 21 | 25 | 2 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.92e-04 | 21 | 25 | 2 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.92e-04 | 21 | 25 | 2 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.21e-04 | 22 | 25 | 2 | GO:0030853 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.37e-04 | 113 | 25 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase A signaling | 3.51e-04 | 23 | 25 | 2 | GO:0010738 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.51e-04 | 23 | 25 | 2 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.51e-04 | 23 | 25 | 2 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.83e-04 | 24 | 25 | 2 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.83e-04 | 24 | 25 | 2 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.83e-04 | 24 | 25 | 2 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.16e-04 | 25 | 25 | 2 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.16e-04 | 25 | 25 | 2 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.86e-04 | 27 | 25 | 2 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.23e-04 | 28 | 25 | 2 | GO:0034111 | |
| GeneOntologyBiologicalProcess | behavior | 5.58e-04 | 891 | 25 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 5.61e-04 | 29 | 25 | 2 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 6.42e-04 | 31 | 25 | 2 | GO:0010544 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 6.53e-04 | 334 | 25 | 4 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 6.53e-04 | 334 | 25 | 4 | GO:0001894 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 6.58e-04 | 142 | 25 | 3 | GO:0046683 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 6.84e-04 | 32 | 25 | 2 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 6.84e-04 | 32 | 25 | 2 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 6.84e-04 | 32 | 25 | 2 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 7.28e-04 | 33 | 25 | 2 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 7.28e-04 | 33 | 25 | 2 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.73e-04 | 34 | 25 | 2 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.73e-04 | 34 | 25 | 2 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 8.19e-04 | 35 | 25 | 2 | GO:1901142 | |
| GeneOntologyBiologicalProcess | feeding behavior | 9.63e-04 | 162 | 25 | 3 | GO:0007631 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 9.65e-04 | 38 | 25 | 2 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.02e-03 | 39 | 25 | 2 | GO:0045717 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.03e-03 | 166 | 25 | 3 | GO:0014074 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.07e-03 | 40 | 25 | 2 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.07e-03 | 40 | 25 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.12e-03 | 41 | 25 | 2 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.18e-03 | 42 | 25 | 2 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.35e-03 | 45 | 25 | 2 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.41e-03 | 46 | 25 | 2 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.41e-03 | 46 | 25 | 2 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.47e-03 | 47 | 25 | 2 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.47e-03 | 47 | 25 | 2 | GO:0001911 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 1.47e-03 | 47 | 25 | 2 | GO:0045494 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.47e-03 | 47 | 25 | 2 | GO:0034104 | |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 1.54e-03 | 48 | 25 | 2 | GO:0010737 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.60e-03 | 49 | 25 | 2 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.60e-03 | 49 | 25 | 2 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.67e-03 | 50 | 25 | 2 | GO:0002834 | |
| GeneOntologyBiologicalProcess | action potential | 1.79e-03 | 201 | 25 | 3 | GO:0001508 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.80e-03 | 52 | 25 | 2 | GO:0031342 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.87e-03 | 53 | 25 | 2 | GO:0071320 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.87e-03 | 53 | 25 | 2 | GO:0034110 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.09e-03 | 56 | 25 | 2 | GO:0002418 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 2.16e-03 | 57 | 25 | 2 | GO:0050974 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.31e-03 | 59 | 25 | 2 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.39e-03 | 60 | 25 | 2 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.39e-03 | 60 | 25 | 2 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.47e-03 | 61 | 25 | 2 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.47e-03 | 61 | 25 | 2 | GO:0003254 | |
| GeneOntologyBiologicalProcess | retina homeostasis | 2.72e-03 | 64 | 25 | 2 | GO:0001895 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 2.88e-03 | 66 | 25 | 2 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.97e-03 | 67 | 25 | 2 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.15e-03 | 69 | 25 | 2 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.24e-03 | 70 | 25 | 2 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.24e-03 | 70 | 25 | 2 | GO:1900047 | |
| GeneOntologyBiologicalProcess | female pregnancy | 3.29e-03 | 249 | 25 | 3 | GO:0007565 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.33e-03 | 71 | 25 | 2 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.33e-03 | 71 | 25 | 2 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 3.42e-03 | 72 | 25 | 2 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.42e-03 | 72 | 25 | 2 | GO:0050819 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 3.49e-03 | 1272 | 25 | 6 | GO:1901698 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 3.52e-03 | 73 | 25 | 2 | GO:0042304 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 3.71e-03 | 75 | 25 | 2 | GO:0050982 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 3.80e-03 | 76 | 25 | 2 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.21e-03 | 80 | 25 | 2 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 4.21e-03 | 80 | 25 | 2 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 4.31e-03 | 81 | 25 | 2 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 4.52e-03 | 83 | 25 | 2 | GO:0048168 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 4.52e-03 | 83 | 25 | 2 | GO:0002707 | |
| GeneOntologyCellularComponent | HCN channel complex | 8.23e-06 | 4 | 25 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | cell surface | 2.98e-05 | 1111 | 25 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.63e-04 | 16 | 25 | 2 | GO:0070021 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.29e-04 | 320 | 25 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | apical dendrite | 6.66e-04 | 32 | 25 | 2 | GO:0097440 | |
| GeneOntologyCellularComponent | basal plasma membrane | 7.72e-04 | 354 | 25 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 9.85e-04 | 378 | 25 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.60e-03 | 431 | 25 | 4 | GO:0031253 | |
| GeneOntologyCellularComponent | axon terminus | 1.95e-03 | 210 | 25 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.10e-03 | 785 | 25 | 5 | GO:0098797 | |
| GeneOntologyCellularComponent | neuron projection terminus | 2.62e-03 | 233 | 25 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.74e-03 | 835 | 25 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.90e-03 | 78 | 25 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | neuron projection membrane | 4.30e-03 | 82 | 25 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | cell body | 4.34e-03 | 929 | 25 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | receptor complex | 4.70e-03 | 581 | 25 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 5.16e-03 | 90 | 25 | 2 | GO:0016328 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 5.27e-03 | 91 | 25 | 2 | GO:0008076 | |
| GeneOntologyCellularComponent | terminal bouton | 5.85e-03 | 96 | 25 | 2 | GO:0043195 | |
| GeneOntologyCellularComponent | ciliary membrane | 6.08e-03 | 98 | 25 | 2 | GO:0060170 | |
| GeneOntologyCellularComponent | potassium channel complex | 6.83e-03 | 104 | 25 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 8.15e-03 | 350 | 25 | 3 | GO:0098802 | |
| Domain | Ion_trans_N | 1.03e-05 | 4 | 25 | 2 | PF08412 | |
| Domain | Ion_trans_N | 1.03e-05 | 4 | 25 | 2 | IPR013621 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.55e-04 | 14 | 25 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 2.04e-04 | 16 | 25 | 2 | IPR018488 | |
| Domain | Ion_trans_dom | 4.62e-04 | 114 | 25 | 3 | IPR005821 | |
| Domain | Ion_trans | 4.62e-04 | 114 | 25 | 3 | PF00520 | |
| Domain | Ricin_B_lectin | 5.06e-04 | 25 | 25 | 2 | PF00652 | |
| Domain | RICIN | 6.36e-04 | 28 | 25 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 6.36e-04 | 28 | 25 | 2 | PS50231 | |
| Domain | Glyco_trans_2-like | 7.31e-04 | 30 | 25 | 2 | IPR001173 | |
| Domain | Ricin_B_lectin | 7.31e-04 | 30 | 25 | 2 | IPR000772 | |
| Domain | Glycos_transf_2 | 7.31e-04 | 30 | 25 | 2 | PF00535 | |
| Domain | CNMP_BINDING_1 | 8.32e-04 | 32 | 25 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 8.32e-04 | 32 | 25 | 2 | PS00889 | |
| Domain | cNMP | 9.40e-04 | 34 | 25 | 2 | SM00100 | |
| Domain | cNMP_binding | 9.40e-04 | 34 | 25 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 9.96e-04 | 35 | 25 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 9.96e-04 | 35 | 25 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 1.17e-03 | 38 | 25 | 2 | IPR018490 | |
| Domain | - | 1.87e-03 | 48 | 25 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 2.11e-03 | 51 | 25 | 2 | IPR014710 | |
| Domain | Ig_2 | 4.26e-03 | 73 | 25 | 2 | PF13895 | |
| Domain | - | 5.22e-03 | 81 | 25 | 2 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 6.14e-03 | 88 | 25 | 2 | IPR029044 | |
| Pubmed | Control of mouse hepatitis virus replication in macrophages by a recessive gene on chromosome 7. | 1.48e-07 | 15 | 25 | 3 | 6327825 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19135060 | ||
| Pubmed | Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity. | 4.96e-07 | 2 | 25 | 2 | 23878236 | |
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 4.96e-07 | 2 | 25 | 2 | 17548059 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 4.96e-07 | 2 | 25 | 2 | 11675786 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 2346748 | ||
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 1.49e-06 | 3 | 25 | 2 | 28131828 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 33181864 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 2341148 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 1.49e-06 | 3 | 25 | 2 | 22652004 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 21187420 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 21945247 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 22006928 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 16043489 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 2.97e-06 | 4 | 25 | 2 | 9630217 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9405696 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 12928435 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 21615589 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 20140458 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 34429357 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 4.95e-06 | 5 | 25 | 2 | 15564593 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 25761792 | ||
| Pubmed | 7.94e-06 | 54 | 25 | 3 | 8482578 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 1.04e-05 | 7 | 25 | 2 | 19421833 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.04e-05 | 7 | 25 | 2 | 7794280 | |
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 16382102 | ||
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 2.32e-05 | 77 | 25 | 3 | 16944957 | |
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 3.26e-05 | 12 | 25 | 2 | 17482496 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.85e-05 | 13 | 25 | 2 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.85e-05 | 13 | 25 | 2 | 1985902 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 15207636 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19285068 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 21760897 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 1719235 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 10964771 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.85e-05 | 13 | 25 | 2 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.85e-05 | 13 | 25 | 2 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.85e-05 | 13 | 25 | 2 | 1326665 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 20044046 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 32150576 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 21081647 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.85e-05 | 13 | 25 | 2 | 39168268 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 22469976 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 11483763 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.85e-05 | 13 | 25 | 2 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.85e-05 | 13 | 25 | 2 | 28035001 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.85e-05 | 13 | 25 | 2 | 12832451 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.85e-05 | 13 | 25 | 2 | 15316023 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 8402684 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.85e-05 | 13 | 25 | 2 | 21670291 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 22162753 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 2164599 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.85e-05 | 13 | 25 | 2 | 23935487 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 2702644 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 16619040 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 8380065 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 1279194 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 15331748 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.85e-05 | 13 | 25 | 2 | 8209741 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.85e-05 | 13 | 25 | 2 | 22406619 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.85e-05 | 13 | 25 | 2 | 21949477 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 29396368 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 26219866 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 7628460 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 25724769 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 18003729 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 26284027 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 2133556 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 32521208 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 26374765 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 3.85e-05 | 13 | 25 | 2 | 33352461 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19406938 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 38381498 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 20739537 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.85e-05 | 13 | 25 | 2 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.85e-05 | 13 | 25 | 2 | 29967450 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.85e-05 | 13 | 25 | 2 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.85e-05 | 13 | 25 | 2 | 27695943 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.85e-05 | 13 | 25 | 2 | 22092845 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 16680193 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 11801635 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 26911181 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 1653760 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 28913658 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 3.85e-05 | 13 | 25 | 2 | 32027621 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19008452 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 18544705 | ||
| Cytoband | 19q13.2 | 3.61e-03 | 164 | 25 | 2 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q25 | 4.32e-03 | 180 | 25 | 2 | chr3q25 | |
| GeneFamily | Cyclic nucleotide gated channels | 4.68e-05 | 10 | 19 | 2 | 250 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.72e-05 | 11 | 19 | 2 | 1315 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 1.97e-04 | 20 | 19 | 2 | 433 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.25e-02 | 163 | 19 | 2 | 590 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP | 7.98e-06 | 41 | 25 | 3 | M14383 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 3.74e-05 | 201 | 25 | 4 | MM1294 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 160 | 25 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 160 | 25 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 164 | 25 | 3 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-04 | 165 | 25 | 3 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.09e-04 | 167 | 25 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 168 | 25 | 3 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 168 | 25 | 3 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 169 | 25 | 3 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 169 | 25 | 3 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 170 | 25 | 3 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 173 | 25 | 3 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 176 | 25 | 3 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 184 | 25 | 3 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 185 | 25 | 3 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 185 | 25 | 3 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 185 | 25 | 3 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.50e-04 | 186 | 25 | 3 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.50e-04 | 186 | 25 | 3 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.50e-04 | 186 | 25 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | (5)_Epi_basal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.62e-04 | 191 | 25 | 3 | 6bda3d5a8a391d41bb4d65872492e6c094bcc4d4 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 191 | 25 | 3 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 193 | 25 | 3 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_basal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.69e-04 | 194 | 25 | 3 | b887b2ff19b76bd93c67f9a24762efae816efd45 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 196 | 25 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.80e-04 | 198 | 25 | 3 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 200 | 25 | 3 | 14f3fe19b6647b32a5e28d717235741997d8522c | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.72e-04 | 51 | 25 | 2 | a6f623dba72ce85683e692a68095926e4e71b765 | |
| ToppCell | control-Epithelial-Secretory-diff|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.80e-04 | 69 | 25 | 2 | 2c1eb6b358c323b4b6a642f473068681987a9e91 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.18e-03 | 91 | 25 | 2 | 9c61b9f3e9e4f0c9cb242e313d642c2b75705c88 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.31e-03 | 96 | 25 | 2 | b671ae6a00b2f4ddf18d7a0b0cb15c34d9fb2a69 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.56e-03 | 105 | 25 | 2 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.56e-03 | 105 | 25 | 2 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.56e-03 | 105 | 25 | 2 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 106 | 25 | 2 | d8868c10785e52a1c22c91e1d0e208f2070393bb | |
| ToppCell | moderate-Epithelial-Secretory-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.68e-03 | 109 | 25 | 2 | f2a07c6a71f6e4587bdc7b85f915bd287028cf17 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.77e-03 | 112 | 25 | 2 | cb351e57c99aaaf9ae6c7ff7e8ce5375552b1639 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.77e-03 | 112 | 25 | 2 | 999b5eeed4305e1a1385aadbaf017b64f21c1ee0 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.77e-03 | 112 | 25 | 2 | 004cd69b66c3b26b9a61f03279b48230da351574 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.77e-03 | 112 | 25 | 2 | 502e3f356f6e1c959bff0a39c98f33f863ce8265 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 118 | 25 | 2 | d0dd5c882cd9e0a5eb0cb08e47877292126bd4ae | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 118 | 25 | 2 | 4283699cb3ca7a112faa07727dfdc0b0a67fb779 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 122 | 25 | 2 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 122 | 25 | 2 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 122 | 25 | 2 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.17e-03 | 124 | 25 | 2 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-03 | 124 | 25 | 2 | 80526f503e1477b9455d10f27f7e6b56caea3a66 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.38e-03 | 130 | 25 | 2 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.42e-03 | 131 | 25 | 2 | c847dcdfb94feb9e1dfc072a162d2b1b6f3d59e4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-03 | 132 | 25 | 2 | 694b79dc31b8d7ef3c01962916d25980b76da33e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-03 | 132 | 25 | 2 | 36bb06f9e97a8abbea4d06beff9e38641a5f0ff2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-03 | 135 | 25 | 2 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-03 | 136 | 25 | 2 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.64e-03 | 137 | 25 | 2 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.64e-03 | 137 | 25 | 2 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.64e-03 | 137 | 25 | 2 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | facs-Skin-Anagen-24m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 138 | 25 | 2 | e8faf333553273b68a10b01470bb43a0383d6212 | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-03 | 138 | 25 | 2 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-03 | 138 | 25 | 2 | cd2f4682fcfd0275ce0640150bbb18da839e5c0a | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-03 | 138 | 25 | 2 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-03 | 139 | 25 | 2 | 6396434c1cb209193ccdf15581ec2adacf941d85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-03 | 139 | 25 | 2 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | MS-CD4-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 2.79e-03 | 141 | 25 | 2 | df257dd4dcc45c1ace57340798e150a6e932531d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-03 | 144 | 25 | 2 | f769be4da268980ea7c06d7097ec39d06777e675 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 2.95e-03 | 145 | 25 | 2 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-03 | 145 | 25 | 2 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-03 | 146 | 25 | 2 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.99e-03 | 146 | 25 | 2 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-03 | 147 | 25 | 2 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-03 | 148 | 25 | 2 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-03 | 148 | 25 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.11e-03 | 149 | 25 | 2 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.11e-03 | 149 | 25 | 2 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-03 | 149 | 25 | 2 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | Serous|World / shred by cell class for turbinate | 3.15e-03 | 150 | 25 | 2 | 6a326662d58b0f17d6efa8cc28571f4cbbf57c2d | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-03 | 154 | 25 | 2 | 1c62290a2558fd6401b27de5a867d243b143b00a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-03 | 154 | 25 | 2 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-03 | 155 | 25 | 2 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-03 | 155 | 25 | 2 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-03 | 155 | 25 | 2 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TEM|Bac-SEP / Disease, Lineage and Cell Type | 3.40e-03 | 156 | 25 | 2 | ef6bad99bcb30956863cd490c613e251f3b27ba0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-03 | 156 | 25 | 2 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.44e-03 | 157 | 25 | 2 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-03 | 157 | 25 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-03 | 158 | 25 | 2 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-03 | 158 | 25 | 2 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.49e-03 | 158 | 25 | 2 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-03 | 159 | 25 | 2 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-03 | 159 | 25 | 2 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-03 | 159 | 25 | 2 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-03 | 159 | 25 | 2 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| Computational | Neighborhood of CDKN1C | 6.25e-04 | 27 | 15 | 2 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 8.80e-04 | 32 | 15 | 2 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.05e-03 | 35 | 15 | 2 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.52e-03 | 42 | 15 | 2 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.82e-03 | 46 | 15 | 2 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.06e-03 | 49 | 15 | 2 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.14e-03 | 50 | 15 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED | |
| Drug | AC1LA3FP | 3.47e-06 | 3 | 25 | 2 | CID000480798 | |
| Drug | cinnabarinic acid | 1.16e-05 | 5 | 25 | 2 | CID000114918 | |
| Drug | oxygen | 1.34e-05 | 499 | 25 | 6 | CID000000977 | |
| Drug | 3,4-dihydroxybenzyl alcohol | 1.73e-05 | 6 | 25 | 2 | CID000100733 | |
| Drug | dimethoxyphenol | 1.73e-05 | 6 | 25 | 2 | CID000078828 | |
| Drug | midodrine | 1.84e-05 | 47 | 25 | 3 | CID000004195 | |
| Drug | AC1Q5IY7 | 2.42e-05 | 7 | 25 | 2 | CID000161776 | |
| Drug | 6-hydroxydopamine quinone | 2.42e-05 | 7 | 25 | 2 | CID000204080 | |
| Drug | p-hydroxymandelic acid | 3.23e-05 | 8 | 25 | 2 | CID000000328 | |
| Drug | Mn(III)TMPyP | 4.15e-05 | 9 | 25 | 2 | CID005486195 | |
| Drug | isoliquiritin | 4.15e-05 | 9 | 25 | 2 | CID005318591 | |
| Drug | 4,5-DKT | 4.15e-05 | 9 | 25 | 2 | CID000130948 | |
| Drug | pP-8 | 5.18e-05 | 10 | 25 | 2 | CID000444681 | |
| Drug | propofol | 5.29e-05 | 191 | 25 | 4 | CID000004943 | |
| Drug | L-beta-aspartyl phosphate | 5.84e-05 | 69 | 25 | 3 | CID000000832 | |
| Drug | AP1-5 | 6.33e-05 | 11 | 25 | 2 | CID000062693 | |
| Drug | phenoxazinone | 6.33e-05 | 11 | 25 | 2 | CID000114834 | |
| Drug | 16-epiestriol | 8.11e-05 | 77 | 25 | 3 | CID000003269 | |
| Drug | menthol | 1.17e-04 | 87 | 25 | 3 | CID000001254 | |
| Drug | hydroxyindole | 1.20e-04 | 15 | 25 | 2 | CID000075421 | |
| Drug | PE-W | 1.38e-04 | 16 | 25 | 2 | CID016040251 | |
| Drug | zatebradine | 1.56e-04 | 17 | 25 | 2 | CID000065637 | |
| Drug | cyanide | 1.59e-04 | 254 | 25 | 4 | CID000000768 | |
| Drug | isovanillin | 1.75e-04 | 18 | 25 | 2 | CID000012127 | |
| Drug | loperamide | 2.04e-04 | 105 | 25 | 3 | CID000003954 | |
| Drug | HCNs | 2.17e-04 | 20 | 25 | 2 | CID006857665 | |
| Drug | 3,4-dihydroxyphenylglycine | 2.40e-04 | 21 | 25 | 2 | CID000027915 | |
| Drug | AC1L1QCE | 2.64e-04 | 22 | 25 | 2 | CID000008135 | |
| Drug | AP-A | 3.15e-04 | 24 | 25 | 2 | CID000188964 | |
| Drug | copper | 3.42e-04 | 571 | 25 | 5 | CID000023978 | |
| Drug | pU-2 | 3.42e-04 | 25 | 25 | 2 | CID000448973 | |
| Drug | thyronine | 3.70e-04 | 26 | 25 | 2 | CID000102544 | |
| Drug | copper complex | 3.70e-04 | 26 | 25 | 2 | CID000410253 | |
| Drug | tetrahydropterin | 4.00e-04 | 27 | 25 | 2 | CID000122134 | |
| Drug | protocatechuic aldehyde | 4.30e-04 | 28 | 25 | 2 | CID000008768 | |
| Drug | enamines | 4.61e-04 | 29 | 25 | 2 | CID000011642 | |
| Drug | sodium alpha-oxyhyponitrite | 4.94e-04 | 30 | 25 | 2 | CID010129945 | |
| Drug | p-diphenol oxidase | 4.94e-04 | 30 | 25 | 2 | CID003013170 | |
| Drug | indole-2-carboxylic acid | 5.63e-04 | 32 | 25 | 2 | CID000072899 | |
| Drug | DMPD | 5.99e-04 | 33 | 25 | 2 | CID000007472 | |
| Drug | thionitrobenzoate | 5.99e-04 | 33 | 25 | 2 | CID000123648 | |
| Drug | F 10 | 6.36e-04 | 34 | 25 | 2 | CID000209152 | |
| Drug | PhTX-343 | 7.13e-04 | 36 | 25 | 2 | CID000159548 | |
| Drug | ferrocene | 7.94e-04 | 38 | 25 | 2 | CID000007611 | |
| Drug | 1q1g | 8.37e-04 | 39 | 25 | 2 | CID000447992 | |
| Drug | ivabradine | 8.37e-04 | 39 | 25 | 2 | CID000132999 | |
| Drug | DB04006 | 8.80e-04 | 40 | 25 | 2 | CID005289179 | |
| Drug | Piperlongumine [20069-09-4]; Down 200; 12.6uM; HL60; HG-U133A | 9.68e-04 | 179 | 25 | 3 | 1764_DN | |
| Drug | isobutyramide | 9.70e-04 | 42 | 25 | 2 | CID000068424 | |
| Drug | molybdenum | 9.99e-04 | 181 | 25 | 3 | CID000023932 | |
| Drug | AC1L1IPV | 1.02e-03 | 43 | 25 | 2 | CID000004683 | |
| Drug | AC1L1XLP | 1.02e-03 | 43 | 25 | 2 | CID000011554 | |
| Drug | saclofen | 1.06e-03 | 44 | 25 | 2 | CID000122150 | |
| Disease | polypeptide N-acetylgalactosaminyltransferase 16 measurement | 2.07e-06 | 3 | 25 | 2 | EFO_0801900 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 2.07e-06 | 3 | 25 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Glycochenodeoxycholic acid measurement | 4.13e-06 | 4 | 25 | 2 | EFO_0021599 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.47e-05 | 9 | 25 | 2 | C3502809 | |
| Disease | phosphatidylethanolamine ether measurement | 3.09e-05 | 10 | 25 | 2 | EFO_0010229 | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 3.77e-05 | 11 | 25 | 2 | EFO_0801494 | |
| Disease | amyloid plaque accumulation rate | 4.52e-05 | 12 | 25 | 2 | EFO_0007646 | |
| Disease | colorectal cancer, hormone replacement therapy | 5.62e-05 | 88 | 25 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | Tremor, Rubral | 8.21e-05 | 16 | 25 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.21e-05 | 16 | 25 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 8.21e-05 | 16 | 25 | 2 | C0278161 | |
| Disease | Abnormal coordination | 8.21e-05 | 16 | 25 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 8.21e-05 | 16 | 25 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 8.21e-05 | 16 | 25 | 2 | C0240991 | |
| Disease | cD177 antigen measurement | 1.05e-04 | 18 | 25 | 2 | EFO_0021866 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.30e-04 | 20 | 25 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Ataxia | 2.04e-04 | 25 | 25 | 2 | C0004134 | |
| Disease | hearing threshold measurement | 2.57e-04 | 28 | 25 | 2 | EFO_0007618 | |
| Disease | triacylglycerol 52:4 measurement | 4.27e-04 | 36 | 25 | 2 | EFO_0010416 | |
| Disease | clinical treatment | 5.54e-04 | 41 | 25 | 2 | EFO_0007056 | |
| Disease | macrophage migration inhibitory factor measurement | 6.09e-04 | 43 | 25 | 2 | EFO_0008221 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WYVLVMNDEHTERRY | 5996 | Q8WXG9 | |
| LVVLNVYDMYWMNEY | 6 | Q9BSY9 | |
| MQDDISRYDWHYVIL | 631 | Q03468 | |
| AMVYVRGHAEDYERW | 136 | Q8NE62 | |
| AEVWMDEYKQYYYEA | 371 | Q8N428 | |
| NEEYMYAYRWIRNHL | 86 | P48382 | |
| VRHYYIAAEEIIWNY | 371 | P00450 | |
| RHYNLGEYWIEVEME | 61 | P33992 | |
| VVYHVYWLEMVLFYR | 376 | Q9NPH3 | |
| VHLGERMRYAVYWDE | 91 | O94830 | |
| MNGYYIVHYADDDWE | 696 | Q9UIQ6 | |
| RYIHQWEEIFHMTYD | 396 | Q9Y3Q4 | |
| AYNEGDYYHTVLWME | 176 | O15460 | |
| RYIHQWEEIFHMTYD | 276 | O60741 | |
| EQVLVMYHRYWEEYS | 81 | Q13617 | |
| FQWYLDHVYPEMRRY | 446 | Q6IS24 | |
| IWYKGQMRDLYHYIT | 66 | P11464 | |
| FWYKGEMTDLYHYII | 66 | Q00887 | |
| HRWVAEHYFLLMQYD | 96 | P60153 | |
| NIYDLFVWMHYYVSM | 171 | P14679 | |
| ETRDNYFYIHSIWHM | 401 | A6NDV4 | |
| YWDYAMTIRLEEIVY | 311 | Q2NKQ1 | |
| YVMWEMTTQVSHYYL | 201 | P49788 | |
| YWMIFGEVYAYEIDV | 1041 | Q96QT4 | |
| MEEYDWYIFSIVTTY | 161 | Q13224 |